Source: StreetInsider

Press Release: Sunovion : Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma America

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Sunovion Pharmaceuticals Inc., an indirect, wholly owned subsidiary of Sumitomo Pharma Co. Ltd, announced today that it will combine with affiliate companies Sumitomo Pharma America Holdings, Inc., Sumitovant...

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
500-1.0K
Antony Loebel's photo - President & CEO of Sunovion

President & CEO

Antony Loebel

CEO Approval Rating

86/100

Read more